SMS Lifesciences India Ltd Receives EIR with VAI Status from USFDA for API Manufacturing Facility

SMS Lifesciences India Ltd has announced that it has received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. Food and Drug Administration (USFDA) for their API manufacturing facility located at Kazipally, Telangana. This receipt of the EIR reaffirms the company's commitment to maintaining global quality standards and enables access to the regulated US market and other highly regulated global markets.